150 related articles for article (PubMed ID: 6606401)
1. C-reactive protein and serological indices of disease activity in systemic lupus erythematosus.
Bertouch JV; Roberts-Thompson PJ; Feng PH; Bradley J
Ann Rheum Dis; 1983 Dec; 42(6):655-8. PubMed ID: 6606401
[TBL] [Abstract][Full Text] [Related]
2. Complement components, complement activation, and acute phase response in systemic lupus erythematosus.
Sturfelt G; Sjöholm AG
Int Arch Allergy Appl Immunol; 1984; 75(1):75-83. PubMed ID: 6086533
[TBL] [Abstract][Full Text] [Related]
3. Relationship between anti-DNA antibodies complement consumption and circulating immune complexes in systemic lupus erythematosus.
Davis P; Cumming RH; Verrier-Jones J
Clin Exp Immunol; 1977 May; 28(2):226-32. PubMed ID: 301447
[TBL] [Abstract][Full Text] [Related]
4. C-reactive protein and complement components but not other acute-phase reactants discriminate between clinical subsets and organ damage in systemic lupus erythematosus.
Amezcua-Guerra LM; Springall R; Arrieta-Alvarado AA; Rodríguez V; Rivera-Martinez E; Castillo-Martinez D; Bojalil R
Clin Lab; 2011; 57(7-8):607-13. PubMed ID: 21888025
[TBL] [Abstract][Full Text] [Related]
5. Immune complexes, complement, and anti-DNA in exacerbations of systemic lupus erythematosus (SLE).
Lloyd W; Schur PH
Medicine (Baltimore); 1981 May; 60(3):208-17. PubMed ID: 7231154
[TBL] [Abstract][Full Text] [Related]
6. The significance of serial measurement of serum anti-native DNA antibodies and complement C3 and C4 components in the management of patients with systemic lupus erythematosus.
Grennan DM; Moseley A; Sloane D; Pumphrey R; Dick WC; Buchanan WW
Aust N Z J Med; 1977 Dec; 7(6):625-9. PubMed ID: 306817
[TBL] [Abstract][Full Text] [Related]
7. Correlation between the levels of antinuclear antibodies, anti-DNA antibodies, and complement in systemic lupus erythematosus.
Nguyen CP; Cao VV; Fehér J; Gergely P
Acta Med Hung; 1988; 45(2):145-59. PubMed ID: 3266790
[TBL] [Abstract][Full Text] [Related]
8. Peripheral neutrophil CD64 index combined with complement, CRP, WBC count and B cells improves the ability of diagnosing bacterial infection in SLE.
Feng M; Zhang SL; Liang ZJ; Wang YL; Zhao XC; Gao C; Guo H; Luo J
Lupus; 2019 Mar; 28(3):304-316. PubMed ID: 30712491
[TBL] [Abstract][Full Text] [Related]
9. A longitudinal study of high and low avidity antibodies to double-stranded DNA in systemic lupus erythematosus.
McGrath H; Biundo JJ
Arthritis Rheum; 1985 Apr; 28(4):425-30. PubMed ID: 3885960
[TBL] [Abstract][Full Text] [Related]
10. Hypercatabolism of C3 and C4 in active and inactive systemic lupus erythematosus.
Charlesworth JA; Peake PW; Golding J; Mackie JD; Pussell BA; Timmermans V; Wakefield D
Ann Rheum Dis; 1989 Feb; 48(2):153-9. PubMed ID: 2784659
[TBL] [Abstract][Full Text] [Related]
11. Serum ferritin as a serologic marker of activity in systemic lupus erythematosus.
Lim MK; Lee CK; Ju YS; Cho YS; Lee MS; Yoo B; Moon HB
Rheumatol Int; 2001 Apr; 20(3):89-93. PubMed ID: 11354563
[TBL] [Abstract][Full Text] [Related]
12. Determination of circulating immune complexes, C3 and C4 complement components and anti-DNA antibody in different classes of lupus nephritis.
Klein MH; Thorner PS; Yoon SJ; Poucell S; Baumal R
Int J Pediatr Nephrol; 1984 Jun; 5(2):75-82. PubMed ID: 6333404
[TBL] [Abstract][Full Text] [Related]
13. Unresponsiveness of C-reactive protein in the non-infectious inflammation of systemic lupus erythematosus is associated with interleukin 6.
Suh CH; Chun HY; Ye YM; Park HS
Clin Immunol; 2006 Jun; 119(3):291-6. PubMed ID: 16406714
[TBL] [Abstract][Full Text] [Related]
14. Disease activity in the nephritis of systemic lupus erythematosus in relation to serum complement concentrations. DNA-binding capacity and precipitating anti-DNA antibody.
Cameron JS; Lessof MH; Ogg CS; Williams BD; Williams DG
Clin Exp Immunol; 1976 Sep; 25(3):418-27. PubMed ID: 1085678
[TBL] [Abstract][Full Text] [Related]
15. [Circulating interferon in patients with systemic lupus erythematosus. A prospective study].
Dudli C; Kaiser V; Aguet M; Joller H; Pichler WI; Grob PJ; Fontana A
Schweiz Med Wochenschr; 1986 Jan; 116(4):104-9. PubMed ID: 2419975
[TBL] [Abstract][Full Text] [Related]
16. Antiphospholipid Antibodies are Associated with Low Levels of Complement C3 and C4 in Patients with Systemic Lupus Erythematosus.
Garabet L; Gilboe IM; Mowinckel MC; Jacobsen AF; Mollnes TE; Sandset PM; Jacobsen EM
Scand J Immunol; 2016 Aug; 84(2):95-9. PubMed ID: 27135178
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil aggregation induced by sera from patients with active systemic lupus erythematosus.
Abramson SB; Given WP; Edelson HS; Weissmann G
Arthritis Rheum; 1983 May; 26(5):630-6. PubMed ID: 6847725
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R
J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
[TBL] [Abstract][Full Text] [Related]
19. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
[TBL] [Abstract][Full Text] [Related]
20. [Relationship of renal histopathology to immunoglobulin classes and complement fixation of anti-native DNA antibodies and components of immune complexes in patients with systemic lupus erythematosus (author's transl)].
Hashimoto H; Utagawa Y; Yamagata J; Okada T; Shiokawa Y; Suzuki S; Tomiyama T
Ryumachi; 1981 Sep; 21(5):366-74. PubMed ID: 6977194
[No Abstract] [Full Text] [Related]
[Next] [New Search]
